CXCR5 antibodies are biologic agents targeting the C-X-C chemokine receptor type 5 (CXCR5), a G-protein coupled receptor expressed on B cells, follicular helper T (Tfh) cells, and lymphoid tissues . These antibodies modulate immune responses by interfering with CXCL13-mediated signaling, which governs lymphocyte migration to germinal centers .
CXCR5 antibodies exert effects through:
Ligand blockade: Neutralizing CXCL13 to prevent B/Tfh cell migration
Cell depletion: Antibody-dependent cellular cytotoxicity (ADCC) against CXCR5+ B and Tfh cells
Germinal center disruption: Reducing ectopic lymphoid structure formation in autoimmune contexts
Rheumatoid Arthritis (RA):
Systemic Lupus Erythematosus (SLE):
Preclinical studies link CXCL13/CXCR5 axis inhibition to reduced mucosa-associated lymphoid tissue (MALT) lymphoma risk .
VX5/5261:
Anti-CXCL13 Antibodies:
Target redundancy: CXCL13 signals through multiple receptors in chronic inflammation .
Vaccine response: PF-06835375 did not impair meningococcal/tetanus vaccine efficacy in trials .
CXE15 (carboxylesterase 15) is an enzyme in Arabidopsis thaliana that plays a crucial role in depleting strigolactones, which are phytohormones that coordinate various growth and developmental processes . Antibodies against CXE15 are valuable research tools for:
Detecting protein expression levels in different plant tissues
Immunoprecipitation experiments to study protein-protein interactions
Immunohistochemistry to determine spatial localization
Western blotting to quantify expression under various conditions
Tracking post-translational modifications
The N-terminal region of CXE15 is characterized by an alpha helix structure, which differs from related enzymes like CXE20 (which displays an alpha/beta fold) . This structural distinction makes specific antibody detection particularly valuable for distinguishing between these related carboxylesterases.
CXE15 antibodies can be applied to various sample types, similar to other plant protein antibodies:
Sample Type | Preparation Method | Applications |
---|---|---|
Plant tissue extracts | Homogenization in appropriate buffer with protease inhibitors | Western blotting, ELISA |
Fixed tissue sections | Paraffin embedding or cryosectioning | Immunohistochemistry, immunofluorescence |
Cell suspensions | Fixation and permeabilization | Flow cytometry, immunocytochemistry |
Purified protein | Recombinant expression or native purification | Binding assays, structural studies |
When preparing samples, it's critical to consider the subcellular localization of CXE15 and use appropriate extraction methods to ensure efficient protein recovery while maintaining the epitope integrity for antibody recognition.
Proper controls are essential for interpreting antibody-based experimental results:
Positive Control: Samples known to express CXE15 (e.g., tissues where strigolactone catabolism is active)
Negative Control: Samples from CXE15 knockout plants or tissues known not to express CXE15
Isotype Control: Non-specific antibody of the same isotype to assess background binding
Blocking Peptide Control: Pre-incubation of antibody with the immunizing peptide to confirm specificity
Secondary Antibody Control: Omitting primary antibody to assess non-specific binding of secondary antibody
Similar to validation approaches used with other antibodies, researchers should consider using genetic knockouts of CXE15 as the gold standard negative control, as demonstrated with CXCR5 antibody validation where knockout cell lines were employed .
CXE15 antibodies enable sophisticated investigations into strigolactone (SL) regulation:
Developmental Expression Profiling: Using immunoblotting to track CXE15 expression across developmental stages to correlate with SL-dependent phenotypes
Environmental Response Studies: Quantifying CXE15 expression changes under different environmental conditions (drought, nutrient availability, light conditions) to understand SL catabolism regulation
Co-localization Studies: Combining CXE15 antibodies with markers for subcellular compartments to determine where SL degradation occurs
Protein Complex Identification: Using co-immunoprecipitation with CXE15 antibodies to identify interaction partners involved in SL metabolism
Research shows that understanding CXE15 expression patterns can provide insights into when and where plants actively regulate SL levels, as CXE15 participates in post-signaling processes for signal inactivation and cue depletion .
Correlating antibody detection with enzyme activity provides more comprehensive insights:
Method | Technical Approach | Data Obtained |
---|---|---|
Enzyme-Linked Activity Assay | Immobilize CXE15 using antibody, then measure substrate conversion | Direct correlation between protein presence and activity |
Combined Immunoprecipitation/Activity Assay | Pull down CXE15 with antibody, then measure activity on strigolactone substrates | Activity of specific protein populations |
In situ Activity Correlation | Compare immunohistochemistry with activity-based probes in tissue sections | Spatial relationship between protein presence and activity |
Western Blot + Activity Assay | Parallel analysis of protein levels and enzyme activity from the same samples | Quantitative correlation between expression and function |
When designing such experiments, it's important to consider that antibody binding might affect enzyme activity, particularly if the epitope is near the catalytic site. The crystal structures of AtCXE15, both in apo form and with bound SL intermediate , can guide researchers in selecting antibodies that target accessible epitopes without interfering with catalytic function.
While standard CXE15 antibodies detect the protein regardless of phosphorylation status, phospho-specific antibodies can provide insights into regulatory mechanisms:
Phospho-specific Antibody Development: Generate antibodies against predicted phosphorylation sites in CXE15 based on consensus sequences and structural accessibility
2D Gel Electrophoresis + Immunoblotting: Separate proteins by charge and size to detect phosphorylated variants using standard CXE15 antibodies
Phos-tag™ SDS-PAGE: Utilize phosphate-binding molecules to create mobility shifts in phosphorylated proteins, detectable with standard CXE15 antibodies
Combined Phospho-enrichment and Antibody Detection: Use titanium dioxide or IMAC to enrich phosphopeptides prior to detection
Understanding CXE15 phosphorylation may reveal regulatory mechanisms controlling its catalytic activity on strigolactones, providing insights into how plants fine-tune phytohormone levels during development and in response to environmental cues.
Successful immunoprecipitation of CXE15 requires careful optimization:
Parameter | Recommended Approach | Rationale |
---|---|---|
Lysis Buffer | Mild non-ionic detergent (0.5-1% NP-40 or Triton X-100) with protease inhibitors | Preserves protein-protein interactions while solubilizing membranes |
Antibody Binding | Pre-conjugate antibody to beads or use secondary capture | Reduces background from heavy chains in subsequent analysis |
Incubation Time | 2-4 hours at 4°C or overnight | Balances binding efficiency with minimizing non-specific interactions |
Washing Stringency | Progressive washing with increasing salt concentration | Removes non-specific binders while maintaining true interactions |
Elution Method | Low pH or competitive elution with immunizing peptide | Preserves binding partners for downstream analysis |
Given that CXE15 has distinct structural features including an alpha helix in its N-terminal region , researchers should consider whether the antibody epitope remains accessible when the protein is in complex with interaction partners.
Optimizing western blotting for CXE15 requires attention to several parameters:
Sample Preparation: Consider using specialized plant protein extraction buffers containing reducing agents to maintain protein integrity
Gel Percentage: 10-12% polyacrylamide gels typically provide optimal resolution for CXE15 (~42-45 kDa)
Transfer Conditions: Semi-dry transfer at 15-20V for 30-45 minutes or wet transfer at 30V overnight at 4°C
Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature
Antibody Dilution: Start with 1:1000 dilution and optimize based on signal-to-noise ratio
Detection Method: Enhanced chemiluminescence for standard detection or fluorescent secondary antibodies for quantitative analysis
Similar to approaches used with CXCR5 antibodies , performing western blots under reducing conditions with appropriate controls is essential for ensuring specificity. Researchers should also note that boiling samples may cause protein aggregation in some cases, as observed with certain membrane-associated proteins .
Plant tissues present unique challenges for immunohistochemistry:
Fixation: 4% paraformaldehyde is generally suitable; avoid glutaraldehyde which can create high autofluorescence
Permeabilization: Use 0.1-0.3% Triton X-100 to facilitate antibody penetration through cell walls
Antigen Retrieval: Heat-mediated retrieval with citrate buffer (pH 6.0) can improve epitope accessibility
Background Reduction: Pre-incubate sections with 10% normal serum from the species in which the secondary antibody was raised
Signal Amplification: Consider tyramide signal amplification for low-abundance targets
Counterstaining: Use DAPI for nuclei and specific organelle markers to provide context for CXE15 localization
Drawing from techniques used for other antibodies , incubation time optimization (10 minutes to overnight) can significantly impact staining quality and specificity.
When encountering detection problems with CXE15 antibodies:
Issue | Potential Causes | Solutions |
---|---|---|
High background | Non-specific binding, insufficient blocking | Increase blocking time/concentration, add 0.1-0.3% Tween-20, use different blocking agent |
Weak or no signal | Low protein abundance, epitope masking, protein degradation | Increase protein concentration, try different extraction methods, add protease inhibitors |
Multiple bands | Cross-reactivity, protein degradation, isoforms | Increase antibody specificity through affinity purification, use fresher samples, validate with knockout controls |
Inconsistent results | Variable protein extraction efficiency | Standardize tissue harvesting conditions, use internal loading controls |
Learning from antibody validation approaches in other systems , generating and including a CXE15 knockout sample as a negative control provides the strongest evidence for antibody specificity.
Accurate quantification requires rigorous methodology:
Normalization Strategy:
Use multiple housekeeping proteins as internal controls
Consider tissue-specific reference genes for RT-qPCR validation
Include loading controls on every blot
Image Acquisition:
Use dynamic range-appropriate exposure settings
Avoid saturated pixels that compress signal differences
Capture multiple exposures to ensure linearity
Quantification Software:
Employ background subtraction with defined parameters
Use region-of-interest analysis with consistent sizing
Apply lane normalization based on total protein or housekeeping proteins
Statistical Analysis:
Perform technical and biological replicates (minimum n=3)
Apply appropriate statistical tests based on data distribution
Report both fold change and p-values
Following practices like those used in validating CXCR5 antibodies , collecting >5000 events for flow cytometry or using multiple technical repeats for western blotting helps ensure robust quantitative data.
Distinguishing between related carboxylesterases requires strategic approaches:
Epitope Selection: Choose antibodies targeting unique regions, particularly focusing on the N-terminal differences between CXE15 (alpha helix) and CXE20 (alpha/beta fold)
Validation Testing: Test antibodies against recombinant CXE15 and CXE20 to confirm specificity
Pre-absorption Controls: Pre-incubate antibody with recombinant CXE20 to remove cross-reactive antibodies before detecting CXE15
Knockout Validations: Utilize genetic knockouts of either CXE15 or CXE20 to confirm antibody specificity
Size Discrimination: While related, CXE15 and CXE20 may have slightly different molecular weights detectable on high-resolution gels
Similar to validation strategies used for other antibodies , analyzing the antibody's performance in both wild-type and knockout backgrounds provides definitive evidence of specificity.
Cross-species applicability of CXE15 antibodies depends on epitope conservation:
Sequence Alignment Analysis: Compare CXE15 sequences across species to identify conserved epitopes
Cross-Reactivity Testing: Validate antibody binding in related species through western blotting
Heterologous Expression Testing: Express CXE15 orthologs from different species and test antibody recognition
Phylogenetic Correlation: Map antibody reactivity to evolutionary relationships between plant species
Antibodies targeting highly conserved catalytic domains may provide broader cross-species reactivity compared to those targeting variable regions, enabling comparative studies of CXE15 function across different plant families.
Advanced multiplexing approaches include:
Technique | Methodology | Advantages |
---|---|---|
Multi-color Immunofluorescence | Use spectrally distinct fluorophores on antibodies against different pathway components | Visualize spatial relationships between proteins |
Sequential Immunoprecipitation | Use one antibody for IP followed by detection of co-precipitated proteins | Identify protein complexes and their compositions |
Mass Cytometry | Use metal-tagged antibodies with time-of-flight detection | Simultaneously measure multiple proteins at single-cell level |
Proximity Ligation Assay | Generate signal only when two antibody-tagged proteins are in close proximity | Detect protein-protein interactions in situ |
Multiplexing allows researchers to study how CXE15 fits into the broader strigolactone regulatory network, providing insights into protein interaction dynamics and pathway regulation mechanisms that would be difficult to obtain through single-protein studies.